- In September 2024, Merck has achieved industry-first EXCiPACT cGMP certification for Pharmaceutical Auxiliary Materials at its global cell culture media production sites in Germany, the UK, China, and the U.S., ensuring high safety and quality standards for essential raw materials in biomanufacturing
- In September 2024, Cytiva has opened its first Innovation Hub in Songdo, Incheon, Korea, featuring a manufacturing facility and customer experience lab. Set to enhance biopharmaceutical manufacturing, the hub aims for sustainable practices and collaboration, supporting growth in the APAC life sciences industry
- In August 2024, MilliporeSigma, the Life Science business of Merck KGaA, Darmstadt, Germany, has completed its acquisition of Mirus Bio for approximately USD 600 million. This strategic move enhances MilliporeSigma's viral vector bioprocessing capabilities, integrating Mirus Bio's advanced transfection reagents with their extensive bioprocessing portfolio to support cell and gene therapy advancements
- In July 2024, Merck has launched its first GMP-compliant cell culture media manufacturing line in Nantong, China, following a USD 7.284 billioninvestment. This facility enhances production capabilities, supports local biopharma manufacturers, and facilitates faster access to novel medicines and therapies, reinforcing Merck's commitment to the region
- In July 2023, A Sartorius has officially opened a new 21,500-square-foot manufacturing facility for cell culture media at its Yauco site in Puerto Rico. This expansion enhances Sartorius' capacity to produce regulatory-friendly powder media, crucial for biopharmaceutical production. The facility aims to support growing demand in the Americas region and reflects Sartorius' commitment to local operations. With production beginning in spring 2023, the site continues to strengthen Sartorius' role in the biopharmaceutical industry, building on its legacy as the company’s first manufacturing location outside Germany
- In May 2023, Thermo Fisher and BRIN have partnered to enhance research capabilities in Indonesia, focusing on advancing scientific innovation and collaboration in life sciences, biotechnology, and environmental studies for local researchers
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL CELL CULTURE MEDIA MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 GLOBAL CELL CULTURE MEDIA MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING FOCUS ON PERSONALIZED MEDICINE
6.1.2 ADVANCES IN CELL THERAPY AND REGENERATIVE MEDICINE
6.1.3 INCREASE IN R&D SPENDING ON BIOPHARMACEUTICAL PROJECTS
6.1.4 GROWING DEMAND FOR VACCINE DEVELOPMENT
6.2 RESTRAINTS
6.2.1 RISKS ASSOCIATED WITH CONTAMINATION
6.2.2 HIGH COST OF PRODUCTION
6.3 OPPORTUNITIES
6.3.1 RISING COLLABORATION AND PARTNERSHIPS
6.3.2 INCREASED DEMAND FOR BIOPHARMACEUTICALS AND VACCINES
6.3.3 INNOVATIONS IN 3D CELL CULTURE
6.4 CHALLENGES
6.4.1 COMPLEXITY OF MEDIA FORMULATION
6.4.2 INTENSE MARKET COMPETITION
7 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE
7.1 OVERVIEW
7.2 CHEMICALLY DEFINED MEDIA
7.3 CLASSICAL MEDIA
7.4 SERUM-FREE MEDIA
7.4.1 CHO MEDIA
7.4.2 HEK 293 MEDIA
7.4.3 CAR T-CELL MEDIA
7.4.4 VERO CELL MEDIA
7.4.5 BHK MEDIA
7.4.6 INSECT CELL MEDIA
7.4.7 SERUM-FREE CELL MEDIA
7.4.8 OTHER SERUM-FREE MEDIA
7.5 SPECIALTY MEDIA
7.6 STEM CELL MEDIA
7.6.1 MESENCHYMAL STEM CELLS (MSCS)
7.6.2 NEURAL STEM CELLS (NSCS)
7.6.3 EMBRYONIC STEM CELLS (ESCS)
7.6.4 BONE MARROW
7.6.5 OTHERS
7.7 LYSOGENY BROTH (LB)
7.8 CUSTOM MEDIA FORMULATION
7.9 OTHERS
8 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 BIOPHARMACEUTICAL PRODUCTION
8.2.1 MONOCLONAL ANTIBODIES
8.2.2 VACCINES PRODUCTION
8.2.3 OTHERS
8.3 DRUG SCREENING & DEVELOPMENT
8.4 DIAGNOSTICS
8.5 REGENERATIVE MEDICINE & TISSUE ENGINEERING
8.5.1 STEM CELL AND GENE THERAPY
8.5.2 OTHERS
8.6 OTHERS
9 GLOBAL CELL CULTURE MEDIA MARKET, BY END USER
9.1 OVERVIEW
9.2 BIOPHARMACEUTICAL COMPANIES
9.3 BIOTECHNOLOGY ORGANIZATIONS
9.4 ACADEMIC AND RESEARCH LABORATORIES
9.5 HOSPITALS
9.6 DIAGNOSTIC CENTERS
9.7 CELL BANKS
9.8 FORENSIC LABORATORIES
9.9 OTHERS
10 GLOBAL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DIRECT TENDERS
10.3 THIRD PARTY DISTRIBUTION
10.4 RETAILS SALES
11 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 GERMANY
11.3.2 U.K.
11.3.3 FRANCE
11.3.4 NETHERLANDS
11.3.5 SPAIN
11.3.6 SWITZERLAND
11.3.7 BELGIUM
11.3.8 ITALY
11.3.9 RUSSIA
11.3.10 TURKEY
11.3.11 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 JAPAN
11.4.3 INDIA
11.4.4 SOUTH KOREA
11.4.5 AUSTRALIA
11.4.6 SINGAPORE
11.4.7 THAILAND
11.4.8 MALAYSIA
11.4.9 INDONESIA
11.4.10 PHILIPPINES
11.4.11 REST OF ASIA-PACIFIC
11.5 SOUTH AMERICA
11.5.1 BRAZIL
11.5.2 ARGENTINA
11.5.3 REST OF SOUTH AMERICA
11.6 MIDDLE EAST AND AFRICA
11.6.1 SOUTH AFRICA
11.6.2 SAUDI ARABIA
11.6.3 U.A.E
11.6.4 EGYPT
11.6.5 ISRAEL
11.6.6 REST OF MIDDLE EAST AND AFRICA
12 GLOBAL MULTIPLE HEREDITARY EXOSTOSIS MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.2 MERCK KGAA
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 DANAHER CORPORATION (CYTIVA)
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 SARTORIUS AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 LONZA
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENT
14.6 CORNING INCORPORATED
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 COMPANY SHARE ANALYSIS
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT UPDATES
14.7 AJINOMOTO CO., INC
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 AKRON BIOTECH
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 BD
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT UPDATES
14.1 BIO-RAD LABORATORIES, INC.
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENT
14.11 CAISSON LABS INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT UPDATES
14.12 CELL APPLICATION, INC.
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT UPDATES
14.13 ELEX BIOLOGICAL PRODUCTS (SHANGHAI) CO., LTD.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 FUJIFILM HOLDINGS CORPORATION
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT UPDATES
14.15 HIMEDIA LABORATORIES
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT UPDATES
14.16 KOH JIN-BIO CO., LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT UPDATES
14.17 PAN-BIOTECH
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT UPDATES
14.18 PROMOCELL GMBH
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT UPDATES
14.19 SERA-SCANDIA A/S
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 STEMCELL TECHNOLOGIES
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 TAKARA BIO INC.
14.21.1 COMPANY SNAPSHOT
14.21.2 REVENUE ANALYSIS
14.21.3 PRODUCT PORTFOLIO
14.21.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 GMP REQUIREMENTS
TABLE 2 SCOPE OF THE CURRENT DOCUMENT
TABLE 3 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 4 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (VOLUME)
TABLE 5 GLOBAL CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (ASP)
TABLE 6 GLOBAL CHEMICALLY DEFINED MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 GLOBAL CLASSICAL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 8 GLOBAL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 9 GLOBAL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 10 GLOBAL SPECIALTY MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 11 GLOBAL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 GLOBAL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 13 GLOBAL LYSOGENY BROTH (LB) IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 14 GLOBAL CUSTOM MEDIA FORMULATION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 15 GLOBAL OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 16 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 17 GLOBAL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 18 GLOBAL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 19 GLOBAL DRUG SCREENING & DEVELOPMENT IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 GLOBAL DIAGNOSTICS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 21 GLOBAL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 GLOBAL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 GLOBAL OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 24 GLOBAL CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 25 GLOBAL BIOPHARMACEUTICAL COMPANIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 26 GLOBAL BIOTECHNOLOGY ORGANIZATIONS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 GLOBAL ACADEMIC AND RESEARCH LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 28 GLOBAL HOSPITALS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 29 GLOBAL DIAGNOSTIC CENTERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 30 GLOBAL CELL BANKS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 31 GLOBAL FORENSIC LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 32 GLOBAL OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 33 GLOBAL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 34 GLOBAL DIRECT TENDERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 35 GLOBAL THIRD PARTY DISTRIBUTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 36 GLOBAL RETAIL SALES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 37 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 38 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 39 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 40 NORTH AMERICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 41 NORTH AMERICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 42 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 43 NORTH AMERICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 44 NORTH AMERICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 45 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 46 NORTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 47 U.S. CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 48 U.S. SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 49 U.S. STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 50 U.S. CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 51 U.S. BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 52 U.S. REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 53 U.S. CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 54 U.S. CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 55 CANADA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 56 CANADA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 57 CANADA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 58 CANADA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 59 CANADA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 60 CANADA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 61 CANADA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 62 CANADA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 63 MEXICO CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 64 MEXICO SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 65 MEXICO STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 66 MEXICO CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 67 MEXICO BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 68 MEXICO REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 69 MEXICO CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 70 MEXICO CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 71 EUROPE CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 72 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 73 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 74 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 75 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 76 EUROPE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 77 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 78 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 79 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 80 GERMANY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 81 GERMANY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 82 GERMANY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 83 GERMANY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 84 GERMANY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 85 GERMANY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 86 GERMANY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 87 GERMANY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 88 U.K. CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 89 U.K. SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 90 U.K. STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 91 U.K. CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 92 U.K. BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 93 U.K. REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 94 U.K. CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 95 U.K. CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 96 FRANCE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 97 FRANCE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 98 FRANCE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 99 FRANCE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 100 FRANCE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 101 FRANCE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 102 FRANCE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 103 FRANCE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 104 NETHERLANDS CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 105 NETHERLANDS SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 106 NETHERLANDS STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 107 NETHERLANDS CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 108 NETHERLANDS BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 109 NETHERLANDS REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 110 NETHERLANDS CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 111 NETHERLANDS CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 112 SPAIN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 113 SPAIN SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 114 SPAIN STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 115 SPAIN CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 116 SPAIN BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 117 SPAIN REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 118 SPAIN CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 119 SPAIN CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 120 SWITZERLAND CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 121 SWITZERLAND SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 122 SWITZERLAND STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 123 SWITZERLAND CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 124 SWITZERLAND BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 125 SWITZERLAND REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 126 SWITZERLAND CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 127 SWITZERLAND CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 128 BELGIUM CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 129 BELGIUM SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 130 BELGIUM STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 BELGIUM CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 132 BELGIUM BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 133 BELGIUM REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 134 BELGIUM CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 135 BELGIUM CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 136 ITALY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 137 ITALY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 138 ITALY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 139 ITALY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 140 ITALY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 141 ITALY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 142 ITALY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 143 ITALY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 144 RUSSIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 145 RUSSIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 146 RUSSIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 147 RUSSIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 148 RUSSIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 149 RUSSIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 150 RUSSIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 151 RUSSIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 152 TURKEY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 153 TURKEY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 154 TURKEY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 155 TURKEY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 156 TURKEY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 157 TURKEY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 158 TURKEY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 159 TURKEY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 160 REST OF EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 161 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 162 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 163 ASIA-PACIFIC SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 164 ASIA-PACIFIC STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 165 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 166 ASIA-PACIFIC BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 167 ASIA-PACIFIC REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 168 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 169 ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 170 CHINA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 171 CHINA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 172 CHINA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 173 CHINA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 174 CHINA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 175 CHINA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 176 CHINA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 177 CHINA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 178 JAPAN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 179 JAPAN SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 180 JAPAN STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 181 JAPAN CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 182 JAPAN BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 183 JAPAN REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 184 JAPAN CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 185 JAPAN CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 186 INDIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 187 INDIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 188 INDIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 189 INDIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 190 INDIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 191 INDIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 192 INDIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 193 INDIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 194 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 195 SOUTH KOREA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 196 SOUTH KOREA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 197 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 198 SOUTH KOREA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 199 SOUTH KOREA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 200 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 201 SOUTH KOREA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 202 AUSTRALIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 203 AUSTRALIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 204 AUSTRALIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 205 AUSTRALIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 206 AUSTRALIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 207 AUSTRALIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 208 AUSTRALIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 209 AUSTRALIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 210 SINGAPORE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 211 SINGAPORE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 212 SINGAPORE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 213 SINGAPORE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 214 SINGAPORE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 215 SINGAPORE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 216 SINGAPORE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 217 SINGAPORE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 218 THAILAND CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 219 THAILAND SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 220 THAILAND STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 221 THAILAND CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 222 THAILAND BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 223 THAILAND REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 224 THAILAND CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 225 THAILAND CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 226 MALAYSIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 227 MALAYSIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 228 MALAYSIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 229 MALAYSIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 230 MALAYSIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 231 MALAYSIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 232 MALAYSIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 233 MALAYSIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 234 INDONESIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 235 INDONESIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 236 INDONESIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 237 INDONESIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 238 INDONESIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 239 INDONESIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 240 INDONESIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 241 INDONESIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 242 PHILIPPINES CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 243 PHILIPPINES SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 244 PHILIPPINES STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 245 PHILIPPINES CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 246 PHILIPPINES BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 247 PHILIPPINES REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 248 PHILIPPINES CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 249 PHILIPPINES CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 250 REST OF ASIA-PACIFIC CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 251 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 252 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 253 SOUTH AMERICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 254 SOUTH AMERICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 255 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 256 SOUTH AMERICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 257 SOUTH AMERICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 258 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 259 SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 260 BRAZIL CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 261 BRAZIL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 262 BRAZIL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 263 BRAZIL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 264 BRAZIL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 265 BRAZIL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 266 BRAZIL CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 267 BRAZIL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 268 ARGENTINA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 269 ARGENTINA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 270 ARGENTINA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 271 ARGENTINA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 272 ARGENTINA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 273 ARGENTINA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 274 ARGENTINA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 275 ARGENTINA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 276 REST OF SOUTH AMERICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 277 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 278 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 279 MIDDLE EAST AND AFRICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 280 MIDDLE EAST AND AFRICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 281 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 282 MIDDLE EAST AND AFRICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 283 MIDDLE EAST AND AFRICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 284 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 285 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 286 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 287 SOUTH AFRICA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 288 SOUTH AFRICA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 289 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 290 SOUTH AFRICA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 291 SOUTH AFRICA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 292 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 293 SOUTH AFRICA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 294 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 295 SAUDI ARABIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 296 SAUDI ARABIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 297 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 298 SAUDI ARABIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 299 SAUDI ARABIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 300 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 301 SAUDI ARABIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 302 U.A.E CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 303 U.A.E SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 304 U.A.E STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 305 U.A.E CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 306 U.A.E BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 307 U.A.E REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 308 U.A.E CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 309 U.A.E CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 310 EGYPT CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 311 EGYPT SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 312 EGYPT STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 313 EGYPT CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 314 EGYPT BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 315 EGYPT REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 316 EGYPT CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 317 EGYPT CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 318 ISRAEL CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 319 ISRAEL SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 320 ISRAEL STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 321 ISRAEL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 322 ISRAEL BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 323 ISRAEL REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 324 ISRAEL CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)
TABLE 325 ISRAEL CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)
TABLE 326 REST OF MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)
List of Figure
FIGURE 1 GLOBAL CELL CULTURE MEDIA MARKET: SEGMENTATION
FIGURE 2 GLOBAL CELL CULTURE MEDIA MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL CELL CULTURE MEDIA MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL CELL CULTURE MEDIA MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL CELL CULTURE MEDIA MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL CELL CULTURE MEDIA MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL CELL CULTURE MEDIA MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL CELL CULTURE MEDIA MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL CELL CULTURE MEDIA MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL CELL CULTURE MEDIA MARKET: SEGMENTATION
FIGURE 11 EXECUTIVE SUMMARY
FIGURE 12 STRATEGIC DECISIONS
FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE IS DRIVING THE GROWTH OF THE GLOBAL CELL CULTURE MEDIA MARKET FROM 2024 TO 2031
FIGURE 14 THE CHEMICALLY DEFINED MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CELL CULTURE MEDIA MARKET IN 2024 AND 2031
FIGURE 15 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL CELL CULTURE MEDIA MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 16 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR CELL CULTURE MEDIA MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 17 DROC ANALYSIS
FIGURE 18 GLOBAL CELL CULTURE MEDIA MARKET: BY TYPE, 2023
FIGURE 19 GLOBAL CELL CULTURE MEDIA MARKET: BY TYPE, 2024-2031 (USD MILLION)
FIGURE 20 GLOBAL CELL CULTURE MEDIA MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 21 GLOBAL CELL CULTURE MEDIA MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 GLOBAL CELL CULTURE MEDIA MARKET: BY APPLICATION, 2023
FIGURE 23 GLOBAL CELL CULTURE MEDIA MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 24 GLOBAL CELL CULTURE MEDIA MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 25 GLOBAL CELL CULTURE MEDIA MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 GLOBAL CELL CULTURE MEDIA MARKET: BY END USER, 2023
FIGURE 27 GLOBAL CELL CULTURE MEDIA MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 28 GLOBAL CELL CULTURE MEDIA MARKET: BY END USER, CAGR (2024-2031)
FIGURE 29 GLOBAL CELL CULTURE MEDIA MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 GLOBAL CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 31 GLOBAL CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 32 GLOBAL CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 33 GLOBAL CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 GLOBAL CELL CULTURE MEDIA MARKET: SNAPSHOT
FIGURE 35 GLOBAL CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)
FIGURE 36 NORTH AMERICA CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)
FIGURE 37 EUROPE CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)
FIGURE 38 ASIA-PACIFIC CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)
